Observational Study of Gut and Skin Microbiome in Vitiligo
This study is looking at the gut and skin microbiome (the community of tiny living things like bacteria that live on and inside us) in people with vitiligo. Researchers want to see if these microbiomes are different in people with vitiligo compared to healthy individuals. They will compare people with vitiligo who have active disease (spreading) and stable disease (not spreading) to healthy volunteers. The study aims to understand if there are differences in the types and amounts of these tiny organisms. To join, you need to be between 18 and 89 years old. The study is considered successful if it can show differences in the microbiome composition and how vitiligo progresses over 12 months. The current recruitment status is unclear.
- Study design
- This is an observational study, meaning researchers will observe participants without giving any specific treatments. It plans to enroll 100 participants.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be observed for 12 months to measure microbiome composition and disease progression.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
The Gut and Skin Microbiome in Vitiligo Disease Progression
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- I. Caroline Le Poole · PRINCIPAL_INVESTIGATOR · Northwestern University
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Microbiome composition12 months
Diversity analysis of microbiome samples in control subjects versus vitiligo subjects (measured by number of bacteria species/sample)
- Disease Progression12 months
Disease progression in control subjects versus vitiligo subjects (measured by VASI score (0-100)).